101 related articles for article (PubMed ID: 4064548)
1. Carcinoma of the cervix: the staging anomaly.
Bond WH
Clin Radiol; 1985 Nov; 36(6):625-8. PubMed ID: 4064548
[TBL] [Abstract][Full Text] [Related]
2. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix.
Kim YB; Lee IJ; Kim SY; Kim JW; Yoon HI; Kim SW; Kim S; Kim YT; Suh CO; Kim GE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1323-8. PubMed ID: 19467800
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
4. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
[TBL] [Abstract][Full Text] [Related]
5. Box diagram to express tumour extent: basis of a new staging system in carcinoma of the cervix?
Ashby M
Australas Radiol; 1989 Feb; 33(1):23-5. PubMed ID: 2712786
[TBL] [Abstract][Full Text] [Related]
6. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone.
Perez CA; Grigsby PW; Nene SM; Camel HM; Galakatos A; Kao MS; Lockett MA
Cancer; 1992 Jun; 69(11):2796-806. PubMed ID: 1571911
[TBL] [Abstract][Full Text] [Related]
7. Management of cervical cancer and surgical-pathological staging (SPS). Report of our clinical case series.
Onnis A; Marchetti M; Maggino T; Cascio A; Cerri G; Dipasquale C; Meneghello E; Romagnolo C; Rozzo ML
Eur J Gynaecol Oncol; 1988; 9(2):115-9. PubMed ID: 3383889
[TBL] [Abstract][Full Text] [Related]
8. Stage Ib, IIa, and IIb cervix cancer, postsurgical staging, and prognosis.
Matsuyama T; Inoue I; Tsukamoto N; Kashimura M; Kamura T; Saito T; Uchino H
Cancer; 1984 Dec; 54(12):3072-7. PubMed ID: 6498784
[TBL] [Abstract][Full Text] [Related]
9. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
[TBL] [Abstract][Full Text] [Related]
11. Stage IB1 vs IB2 carcinoma of the cervix: should the new FIGO staging system define therapy?
Grigsby PW
Gynecol Oncol; 1996 Aug; 62(2):135-6. PubMed ID: 8751539
[No Abstract] [Full Text] [Related]
12. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of FIGO stage I-IIA small-cell neuroendocrine carcinoma of the uterine cervix.
Ning L; Zhang W; Yang J; Cao D; Lang J; Yu M
Int J Gynaecol Obstet; 2018 Sep; 142(3):374-375. PubMed ID: 29858870
[No Abstract] [Full Text] [Related]
14. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
15. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
16. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
[TBL] [Abstract][Full Text] [Related]
17. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.
Reich O; Tamussino K; Lahousen M; Pickel H; Haas J; Winter R
Gynecol Oncol; 2000 Mar; 76(3):331-5. PubMed ID: 10684706
[TBL] [Abstract][Full Text] [Related]
18. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix.
Alfsen GC; Kristensen GB; Skovlund E; Pettersen EO; Abeler VM
Cancer; 2001 Nov; 92(9):2471-83. PubMed ID: 11745305
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies.
Lanciano RM; Won M; Coia LR; Hanks GE
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):667-76. PubMed ID: 2004942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]